FDA: Lowering Orthopedic Opioid Dosing (FLOOD)
FLOOD
Reducing the Use of Opioid Therapy Following Orthopedic Surgery: A Randomized Controlled Trial
1 other identifier
interventional
561
0 countries
N/A
Brief Summary
This randomized trial evaluates an intervention to minimize use of opioids following total hip and total knee replacement. Half the participants will receive an intervention (mailed educational materials, followed by a pharmacist call), and half will receive usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Jul 2015
Typical duration for not_applicable postoperative-pain
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 13, 2015
CompletedFirst Posted
Study publicly available on registry
October 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2017
CompletedJune 6, 2017
June 1, 2017
1.8 years
October 13, 2015
June 2, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Average morphine equivalents
post surgery use of opioids
90 days
Study Arms (2)
Intervention
EXPERIMENTALInformational letter mailed approximately 2 weeks prior to surgery, informational letter mailed approximately 2 weeks post surgery, pharmacist call if refill opioid medicine more than 28 days after surgery
Control
NO INTERVENTIONUsual Care
Interventions
Intervention consisted of a mailing 2 weeks prior to surgery, another 2 weeks post surgery, and a pharmacist intervention if a refill of opioid medication was requested within 90 days of surgery.
Eligibility Criteria
You may qualify if:
- total hip replacement or total knee replacement
- year membership with KPNW prior to enrollment
You may not qualify if:
- managed by pain clinic, in other pain management trial
- patients at low risk of persistent opioid use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- Food and Drug Administration (FDA)collaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David H Smith, RPh, PhD
Kaiser Permanente NW
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2015
First Posted
October 15, 2015
Study Start
July 1, 2015
Primary Completion
March 31, 2017
Study Completion
March 31, 2017
Last Updated
June 6, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share